Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.

The American journal of psychiatry - 1 Aug 2007

Paddock Silvia, Laje Gonzalo, Charney Dennis, Rush A John, Wilson Alexander F, Sorant Alexa J M, Lipsky Robert, Wisniewski Stephen R, Manji Husseini, McMahon Francis J

Abstract excerpt

OBJECTIVE: An initial pharmacogenetic study of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) clinical trial reported an association between genetic variation in the HTR2A gene and outcome of citalopram treatment. By design, the study analyzed only those markers that showed reproducible association in the first wave of genotypes (comprising 1,297 patients) in the complete cohort of patients....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Chromosomes, Human, Pair 13

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Citalopram

Share to Receptor, Serotonin, 5-HT2A

Share to Receptors, Kainic Acid

Share to Receptors, N-Methyl-D-Aspartate

Share to ROC Curve

Share to Selective Serotonin Reuptake Inhibitors

Source

Identifiers

PMID: 17671280
DOI: 10.1176/appi.ajp.2007.06111790

Genes

GRIK4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.PMID 17671280Read ↗

Pharmacogenetics studies in STAR*D: strengths, limitations, and results.Semantic proximity Read ↗

Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients.Semantic proximity Read ↗

Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.Semantic proximity Read ↗

Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.Semantic proximity Read ↗

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.Semantic proximity Read ↗

Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.Semantic proximity Read ↗

Pharmacogenomics with antidepressants in the STAR*D study.Semantic proximity Read ↗

GRIK4 polymorphism and its association with antidepressant response in depressed patients: a meta-analysis.Semantic proximity Read ↗

Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients.Semantic proximity Read ↗

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression.Semantic proximity Read ↗

Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis.Semantic proximity Read ↗

Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.